Abstract:Background and objective: As a Burden of Obstructive Lung Disease (BOLD) collaboration, we studied the prevalence of chronic obstructive pulmonary disease (COPD) and its associated risk factors in a suburban population in Malaysia. Methods: Nonhospitalized men or women of age ≥ 40 years from a Penang district were recruited by stratified simple random sampling. Participants completed detailed questionnaires on respiratory symptoms and exposure to COPD risk factors. Prebronchodilator and post-bronchodilator spi… Show more
“…The high degree of breathlessness, poor health-related quality of life and frequent exacerbations in our cohort may represent a more severe COPD disease that were not adequately addressed or treated in many of our patients. Such frequent exacerbation rates were also reported in other studies involving Malaysia [4,5]. The small number of first-time exacerbators indicates that hospitalized setting is not the ideal place to diagnose COPD early.…”
Section: Discussionmentioning
confidence: 51%
“…In collaboration with Burden of Obstructive Lung Disease (BOLD) initiative, we have recently estimated the COPD prevalence at 3.4% in a suburban population of Malaysia [4]. In a population-based survey of Asia-Pacific countries [5], over half of the interviewed COPD patients from Malaysia reported ≥one exacerbation in the past twelve months and many experienced negative impact on work and activities.…”
Background: Detailed characterization of hospitalized COPD patients and their clinical outcomes in Malaysia is lacking. Such understanding is important to combat the rising COPD burden.
“…The high degree of breathlessness, poor health-related quality of life and frequent exacerbations in our cohort may represent a more severe COPD disease that were not adequately addressed or treated in many of our patients. Such frequent exacerbation rates were also reported in other studies involving Malaysia [4,5]. The small number of first-time exacerbators indicates that hospitalized setting is not the ideal place to diagnose COPD early.…”
Section: Discussionmentioning
confidence: 51%
“…In collaboration with Burden of Obstructive Lung Disease (BOLD) initiative, we have recently estimated the COPD prevalence at 3.4% in a suburban population of Malaysia [4]. In a population-based survey of Asia-Pacific countries [5], over half of the interviewed COPD patients from Malaysia reported ≥one exacerbation in the past twelve months and many experienced negative impact on work and activities.…”
Background: Detailed characterization of hospitalized COPD patients and their clinical outcomes in Malaysia is lacking. Such understanding is important to combat the rising COPD burden.
“…In collaboration with international Burden of Obstructive Lung Disease (BOLD), we published the first robust population-based COPD epidemiology data for Malaysia in 2016. 2 We showed that the estimated prevalence of airflow obstruction (principal COPD feature) of a local suburban area was low (3.4% and 6.5% based on NHANES-derived LLN criteria and fixed forced expiratory volume in 1 s/vital capacity (FEV 1 /VC) ratio, respectively) compared with most sites globally including Asian cities such as Guangzhou, Mumbai and Manila. This appeared to be so despite a similarly high Figure 1 The indelible ink on finger as proof of voting in the 2018 Malaysian general election.…”
“…For instance, Loh et al, in a population-based spirometric testing study in Malaysia reported a lower prevalence of COPD than expected. 4 Nevertheless, the long-term impact of an uncontrolled cigarette industry on an ageing population in Asian countries with large populations is a very grave concern.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.